# Ternary Therapeutics

**Source:** https://www.startuphub.ai/startups/ternary-therapeutics
**Profile type:** Startup

> AI platform for engineering molecular glues to create a new class of medicines.

## About

Ternary Therapeutics is a London-based BioTech startup focused on developing a novel platform that combines physics-informed AI with rapid experimental validation to intentionally engineer molecular glues. Molecular glues are a new class of medicines capable of targeting proteins previously considered undruggable. The company's platform aims to move beyond the historical serendipitous discovery of molecular glues, treating drug discovery as an engineering problem. This approach allows for the predictable design and scaling of these molecules, expanding the range of druggable targets and opening new therapeutic avenues, particularly for inflammatory and neuroinflammatory diseases.

## Key facts

- **Slug:** ternary-therapeutics
- **Website:** https://ternarytx.co.uk
- **Location:** London, United Kingdom
- **Founded:** 2024-01-01 00:00:00
- **Operating status:** Active
- **Total funding:** $4M
- **Sectors / tags:** Biotechnology, Artificial Intelligence, Drug Discovery, Pharmaceuticals, AI, Biotech
- **Social:**
  - LinkedIn: https://www.linkedin.com/company/ternarytx
  - Facebook: http://www.facebook.com/2008

## Frequently asked

### What does Ternary Therapeutics do?

Ternary Therapeutics is a London-based BioTech startup focused on developing a novel platform that combines physics-informed AI with rapid experimental validation to intentionally engineer molecular glues. Molecular glues are a new class of medicines capable of targeting proteins previously considered undruggable. The company's platform aims to move beyond the historical serendipitous discovery of molecular glues, treating drug discovery as an engineering problem. This approach allows for the pr…

### What is Ternary Therapeutics's revenue?

StartupHub estimates Ternary Therapeutics's annual revenue at $609K (range $211K to $1.8M, 34% confidence), based on comparable companies in the sector.

### What is Ternary Therapeutics's valuation?

StartupHub estimates Ternary Therapeutics's effective valuation at $17.1M (range $10.8M to $25.8M, 23% confidence), based on comparable companies in the sector.

### How much funding has Ternary Therapeutics raised?

Ternary Therapeutics has raised a total of $4M in funding. The most recent round on record is Seed.

### Where is Ternary Therapeutics headquartered?

Ternary Therapeutics is headquartered in London, United Kingdom.

### When was Ternary Therapeutics founded?

Ternary Therapeutics was founded in 2024.

### What industry does Ternary Therapeutics operate in?

Ternary Therapeutics operates in Biotechnology, Artificial Intelligence, Drug Discovery, Pharmaceuticals, AI, Biotech.

## JSON-LD

Structured data aligned with this page's `<script type="application/ld+json">` (included when the profile is server-rendered).

```json
{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "BreadcrumbList",
      "itemListElement": [
        {
          "@type": "ListItem",
          "position": 1,
          "name": "Home",
          "item": "https://www.startuphub.ai"
        },
        {
          "@type": "ListItem",
          "position": 2,
          "name": "Startups",
          "item": "https://www.startuphub.ai/startups"
        },
        {
          "@type": "ListItem",
          "position": 3,
          "name": "Ternary Therapeutics",
          "item": "https://www.startuphub.ai/startups/ternary-therapeutics"
        }
      ]
    },
    {
      "@type": "ProfilePage",
      "@id": "https://www.startuphub.ai/startups/ternary-therapeutics#webpage",
      "url": "https://www.startuphub.ai/startups/ternary-therapeutics",
      "name": "Ternary Therapeutics - AI Startup Profile | StartupHub.ai",
      "description": "This is the official profile of Ternary Therapeutics. Ternary Therapeutics is a startup founded in 2024, operating in Biotechnology and Artificial Intelligence. AI platform for engineering molecular glues to create a new class of medicines. Headquartered in London, United Kingdom.",
      "dateModified": "2026-07-01T09:30:43.137864+00:00",
      "mainEntity": {
        "@id": "https://www.startuphub.ai/startups/ternary-therapeutics#organization"
      }
    },
    {
      "@type": "Organization",
      "@id": "https://www.startuphub.ai/startups/ternary-therapeutics#organization",
      "name": "Ternary Therapeutics",
      "url": "https://ternarytx.co.uk",
      "logo": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/c9122d65-2775-45cc-a10e-827d79814f2e-square.png",
      "image": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/c9122d65-2775-45cc-a10e-827d79814f2e-square.png",
      "description": "This is the official profile of Ternary Therapeutics. Ternary Therapeutics is a startup founded in 2024, operating in Biotechnology and Artificial Intelligence. AI platform for engineering molecular glues to create a new class of medicines. Headquartered in London, United Kingdom.",
      "sameAs": [
        "https://www.linkedin.com/company/ternarytx",
        "http://www.facebook.com/2008",
        "https://www.startuphub.ai/startups/ternary-therapeutics"
      ],
      "foundingDate": "2024-01-01 00:00:00",
      "address": {
        "@type": "PostalAddress",
        "addressLocality": "London",
        "addressCountry": "GB"
      },
      "knowsAbout": [
        "Biotechnology",
        "Artificial Intelligence",
        "Drug Discovery",
        "Pharmaceuticals",
        "AI",
        "Biotech"
      ]
    },
    {
      "@type": "Product",
      "@id": "https://www.startuphub.ai/startups/ternary-therapeutics#profile-assessment",
      "name": "Ternary Therapeutics - StartupHub.ai Profile Assessment",
      "url": "https://www.startuphub.ai/startups/ternary-therapeutics",
      "image": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/c9122d65-2775-45cc-a10e-827d79814f2e-square.png",
      "category": "Biotechnology",
      "description": "This is the official profile of Ternary Therapeutics. Ternary Therapeutics is a startup founded in 2024, operating in Biotechnology and Artificial Intelligence. AI platform for engineering molecular glues to create a new class of medicines. Headquartered in London, United Kingdom. Agent Readiness score: 22/100. Full audit: https://www.startuphub.ai/startups/ternary-therapeutics/agent-readiness",
      "brand": {
        "@type": "Brand",
        "name": "Ternary Therapeutics"
      },
      "review": {
        "@type": "Review",
        "author": {
          "@type": "Organization",
          "name": "StartupHub.ai"
        },
        "datePublished": "2026-07-01",
        "name": "Ternary Therapeutics - Profile Score 49/100",
        "reviewBody": "This is the official profile of Ternary Therapeutics. Ternary Therapeutics is a startup founded in 2024, operating in Biotechnology and Artificial Intelligence. AI platform for engineering molecular glues to create a new class of medicines. Headquartered in London, United Kingdom. Agent Readiness score: 22/100. Full audit: https://www.startuphub.ai/startups/ternary-therapeutics/agent-readiness",
        "reviewRating": {
          "@type": "Rating",
          "ratingValue": 49,
          "bestRating": 100,
          "worstRating": 0
        }
      }
    }
  ]
}
```